Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal Demise

Recruiting Observational Study
High Risk Pregnancy Congenital Heart Disease Fetal Hydrops Twin Monochorionic Monoamniotic Placenta Gastroschisis Fetal Demise Stillbirth Fetal Arrhythmia Long QT Syndrome Intrauterine Fetal Death Sudden Infant Death Pregnancy Loss Twin Twin Transfusion Syndrome Birth Defect Fetal Cardiac Anomaly Fetal Cardiac Disorder Fetal Death Brugada Syndrome Fetal Tachycardia
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Female
Study type
Observational
Participants needed
30 (estimated)
Sponsor
Medical College of Wisconsin · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Each year world-wide, 2.5 million fetuses die unexpectedly in the last half of pregnancy, 25,000 in the United States, making fetal demise ten-times more common than Sudden Infant Death Syndrome. This study will apply a novel type of non-invasive monitoring, called fetal magnetocardiography (fMCG) used thus far to successfully evaluate fetal arrhythmias, in order to discover potential hidden elect…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Current pregnancy complicated by one of the five diagnostic categories * prior unexplained Stillbirth at/after 20 weeks gestation * fetal major congenital heart defect * fetal hydrops * fetal gastroschisis * monochorionic twin pregnancy * Subject must be 18 years of…
Contacts

Mara C Koffarnus, MD

414-266-4758

mkoffarn@mcw.edu

CONTACT

Gretchen Eckstein

414-266-3539

geckstein@chw.org

CONTACT